Title The role of NIH in drug development innovation and its impact on patient access : proceedings of a workshop / Francis K. Amankwah, Alexandra Andrada, Sharyl J. Nass, and Theresa Wizemann, rapporteurs ; National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Health Care Services

Published Washington, DC : National Academies Press, [2020]

Click on the following:
EBSCO eBooks

Copies

Description 1 online resource (1 PDF file (xvi, 85 pages)) : illustrations Contents Overview -- The translational research landscape -- Federal biomedical research funding and new drug development -- Impact of patient and technology transfer policies on NIH-funded innovation -- The economics of drug pricing -- Strategies and policies to facilitate translation -- Potential policies to ensure affordable access -- References -- Appendixes Summary To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop Bibliography Includes bibliographical references Notes This activity was supported by Arnold Ventures (formerly the Laura and John Arnold Foundation). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project Description based on online resource; title from PDF title page (viewed May 29, 2020) Subject National Institutes of Health (U.S.) -- Research -- Congresses National Institutes of Health (U.S.) National Institutes of Health (U.S.) Drug development -- United States -- Congresses Drug accessibility -- United States -- Congresses Prescription pricing -- Government policy -- United States -- Congresses Drug Development Prescription Drugs -- economics Biomedical Research -- economics Drug accessibility Drug development Prescription pricing -- Government policy Research United States United States Genre/Form proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. Form Electronic book Author Andrada, Alexandra, rapporteur Nass, Sharyl J., rapporteur Wizemann, Theresa M., rapporteur National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Health Care Services, organizer. National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Health Sciences Policy, organizer. Workshop on the Role of NIH in Drug Development Innovation and Its Impact on Patient Access (2019 : Washington, D.C.) ISBN 9780309498517 0309498511

  Permalink